<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Gerster, Karine</dc:creator>
  <dc:creator>Lauber-Biason, Anna</dc:creator>
  <dc:creator>Schoenle, Eugen J.</dc:creator>
  <dc:date>2017-07-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Steroidogenic factor 1 (SF-1/NR5A1) plays a crucial role in regulating adrenal development, gonad determination and differentiation, and in the hypothalamic-pituitary control of reproduction and metabolism. In men (46, XY), it is known that mutations in SF-1/NR5A1 gene cause a wide phenotypic spectrum with variable degrees of undervirilization. In recent years, the role of SF-1 in the ovarian function was increasingly discussed and alterations in the gene were related to primary ovarian insufficiency. We describe the follow-up of a 46, XX affected woman with a SF-1 mutation and by comparing our case with the known manifestations reported in the literature, we try to further elucidate the function of SF-1 in the ovary. During infancy, adrenal insufficiency was the only clinical sign of the loss-of-function as ovarian development and function seemed normal. To date, this young woman aged 16.5 years shows normal growth, normal BMI and psychomotor development, has a normal puberty and regular menstruation. This report shows one, to date uniquely described, phenotypic variant of SF-1 mutation in a 46, XX affected person with adrenocortical insufficiency but no ovarian dysfunction nor disturbance of pubertal development. To follow the natural history of SF-1 mutation in a 46, XX individual will further shed light on its role in the ovarian function and thus will help to counsel affected patients in future.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/305890</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/305890/files/bia_cfu.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ando.2017.01.002</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Annales d’Endocrinologie. - 2017, vol. 78, no. 3, p. 156–161</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Steroidogenic factor 1</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adrenal insufficiency</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Primary ovarian insufficiency</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Disorder of sexual development</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/616</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Clinical follow-up of the first SF-1 insufficient female patient</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
